Active	Status	Sponsor type	Region	Phase	Filter
13 Active 0 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Baldi, Giacomo G
JADE, NCT06256588: A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma	Recruiting	3	864	Europe, Canada, Japan, US, RoW	Dostarlimab, Placebo	GlaxoSmithKline	Neoplasms, Head and Neck	05/28	07/29
MANEUVER, NCT05804045: Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor	Active, not recruiting	3	90	Europe, Canada, US, RoW	Pimicotinib(ABSK021), Placebo	Abbisko Therapeutics Co, Ltd	Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath	05/26	06/28
ChonDRAgon, NCT04950075: Study of INBRX-109 in Conventional Chondrosarcoma	Recruiting	2	201	Europe, US, RoW	INBRX-109, Placebo	Inhibrx Biosciences, Inc	Conventional Chondrosarcoma	12/24	07/25
ISG-ARTICLE, NCT04383119: Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma	Recruiting	2	100	Europe	Trabectedin, Trabectedin arm, Gemcitabine, Gemcitabine arm, No Intervention: Observational Cohort	Italian Sarcoma Group, PharmaMar	Leiomyosarcoma of Ovary, Soft Tissue Sarcoma	06/24	09/24
ISG-MCS, NCT04305548: Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma	Recruiting	2	16	Europe	Trabectedin	Italian Sarcoma Group, PharmaMar	Mesenchymal Chondrosarcoma	09/24	12/24
TOMAS2, NCT03838744 / 2018-004497-10: Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.	Active, not recruiting	2	126	Europe	Standard arm: Trabectedin in monotherapy, Trabectedin arm, Experimental arm: Trabectedin + Olaparib, Trabectedin+ Olaparib arm	Italian Sarcoma Group, PharmaMar, AstraZeneca	Advanced Soft Tissue Sarcoma	02/25	02/25